LGALS3 and acute myeloid leukemia: AML-MSCs’ proteome and secretome contained increased abundance of galectin-3 (LGALS3), which can support tumor cell survival and may be involved in AL relapse, and also regulates osteogenic and adipogenic differentiation [25].